248 related articles for article (PubMed ID: 19997092)
1. Factors associated with non-adherence to oral medication for inflammatory bowel disease: a systematic review.
Jackson CA; Clatworthy J; Robinson A; Horne R
Am J Gastroenterol; 2010 Mar; 105(3):525-39. PubMed ID: 19997092
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact and drivers of non-adherence to maintenance medication for inflammatory bowel disease.
Selinger CP; Robinson A; Leong RW
Expert Opin Drug Saf; 2011 Nov; 10(6):863-70. PubMed ID: 21548837
[TBL] [Abstract][Full Text] [Related]
3. Patients' beliefs and attitudes about their treatment for inflammatory bowel disease in Korea.
Kim SB; Kim KO; Jang BI; Kim ES; Cho KB; Park KS; Chung MK; Jeon SW;
J Gastroenterol Hepatol; 2016 Mar; 31(3):575-80. PubMed ID: 26313162
[TBL] [Abstract][Full Text] [Related]
4. Barriers to adherence among adolescents with inflammatory bowel disease.
Greenley RN; Stephens M; Doughty A; Raboin T; Kugathasan S
Inflamm Bowel Dis; 2010 Jan; 16(1):36-41. PubMed ID: 19434722
[TBL] [Abstract][Full Text] [Related]
5. Review article: medication non-adherence in ulcerative colitis--strategies to improve adherence with mesalazine and other maintenance therapies.
Hawthorne AB; Rubin G; Ghosh S
Aliment Pharmacol Ther; 2008 Jun; 27(12):1157-66. PubMed ID: 18384664
[TBL] [Abstract][Full Text] [Related]
6. [Treatment adherence and use of complementary and alternative medicine in patients with inflammatory bowel disease].
Lakatos L; Czeglédi Z; Dávid G; Kispál Z; Kiss LS; Palatka K; Kristóf T; Molnár T; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovács A; Rácz I; Lakatos PL
Orv Hetil; 2010 Feb; 151(7):250-8. PubMed ID: 20133244
[TBL] [Abstract][Full Text] [Related]
7. Review article: improving adherence to medication in patients with inflammatory bowel disease.
Robinson A
Aliment Pharmacol Ther; 2008 Mar; 27 Suppl 1():9-14. PubMed ID: 18307644
[TBL] [Abstract][Full Text] [Related]
8. Covert dose reduction is a distinct type of medication non-adherence observed across all care settings in inflammatory bowel disease.
Mountifield R; Andrews JM; Mikocka-Walus A; Bampton P
J Crohns Colitis; 2014 Dec; 8(12):1723-9. PubMed ID: 25263934
[TBL] [Abstract][Full Text] [Related]
9. Perceptions and Attitudes Towards Medication Adherence during Pregnancy in Inflammatory Bowel Disease.
Gallinger ZR; Rumman A; Nguyen GC
J Crohns Colitis; 2016 Aug; 10(8):892-7. PubMed ID: 26896087
[TBL] [Abstract][Full Text] [Related]
10. Revealing the Puzzle of Nonadherence in IBD-Assembling the Pieces.
Eindor-Abarbanel A; Naftali T; Ruhimovich N; Bar-Gil Shitrit A; Sklerovsky-Benjaminov F; Konikoff F; Matalon S; Shirin H; Milgrom Y; Broide E
Inflamm Bowel Dis; 2018 May; 24(6):1352-1360. PubMed ID: 29718228
[TBL] [Abstract][Full Text] [Related]
11. Medication non-adherence in adult patients affected by inflammatory bowel disease: a critical review and update of the determining factors, consequences and possible interventions.
Lenti MV; Selinger CP
Expert Rev Gastroenterol Hepatol; 2017 Mar; 11(3):215-226. PubMed ID: 28099821
[TBL] [Abstract][Full Text] [Related]
12. Adherence to Oral Maintenance Treatment in Adolescents With Inflammatory Bowel Disease.
Spekhorst LM; Hummel TZ; Benninga MA; van Rheenen PF; Kindermann A
J Pediatr Gastroenterol Nutr; 2016 Feb; 62(2):264-70. PubMed ID: 26230905
[TBL] [Abstract][Full Text] [Related]
13. Predictors of medication adherence in inflammatory bowel disease.
Ediger JP; Walker JR; Graff L; Lix L; Clara I; Rawsthorne P; Rogala L; Miller N; McPhail C; Deering K; Bernstein CN
Am J Gastroenterol; 2007 Jul; 102(7):1417-26. PubMed ID: 17437505
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for non-adherence to medication in inflammatory bowel disease patients.
D'Incà R; Bertomoro P; Mazzocco K; Vettorato MG; Rumiati R; Sturniolo GC
Aliment Pharmacol Ther; 2008 Jan; 27(2):166-72. PubMed ID: 17949472
[TBL] [Abstract][Full Text] [Related]
15. Objective versus subjective assessment of oral medication adherence in pediatric inflammatory bowel disease.
Hommel KA; Davis CM; Baldassano RN
Inflamm Bowel Dis; 2009 Apr; 15(4):589-93. PubMed ID: 18985746
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory bowel disease: healthcare costs for patients who are adherent or non-adherent with infliximab therapy.
Wan GJ; Kozma CM; Slaton TL; Olson WH; Feagan BG
J Med Econ; 2014 Jun; 17(6):384-93. PubMed ID: 24673303
[TBL] [Abstract][Full Text] [Related]
17. Socioeconomic and psychological factors associated with nonadherence to treatment in inflammatory bowel disease patients: results of the ISSEO survey.
Nahon S; Lahmek P; Saas C; Durance C; Olympie A; Lesgourgues B; Gendre JP
Inflamm Bowel Dis; 2011 Jun; 17(6):1270-6. PubMed ID: 21560190
[TBL] [Abstract][Full Text] [Related]
18. Oral medication adherence in pediatric inflammatory bowel disease.
Mackner LM; Crandall WV
Inflamm Bowel Dis; 2005 Nov; 11(11):1006-12. PubMed ID: 16239847
[TBL] [Abstract][Full Text] [Related]
19. May you never forget what is worth remembering: the relation between recall of medical information and medication adherence in patients with inflammatory bowel disease.
Linn AJ; van Dijk L; Smit EG; Jansen J; van Weert JC
J Crohns Colitis; 2013 Dec; 7(11):e543-50. PubMed ID: 23660489
[TBL] [Abstract][Full Text] [Related]
20. [The problems of compliance and adherence, using the example of chronic inflammatory bowel disease].
Zimmerer T; Siegmund SV; Singer MV
Dtsch Med Wochenschr; 2009 Jul; 134(27):1417-24. PubMed ID: 19551607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
